Notice Regarding the Announcement Date of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027
We hereby announce that, as disclosed in the " Notice Regarding the Disclosure of the Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 Exceeding 45 Days After the End of the Quarter" announced on August 12, 2026, the Company postponed the announcement of its financial results for the first quarter of the fiscal year ending March 31, 2027 and has been conducting an investigation into certain questions regarding the accounting treatment at its consolidated subsidiary, Takara Bio USA, Inc., with the assistance of legal experts and certified public accountants.
The investigation has now been completed, and we have obtained a clearer outlook regarding the schedule for the announcement of its financial results. Accordingly, we have determined that the announcement date for the financial results for the first quarter of the fiscal year ending March 31, 2027 will be October 23,2026.
The financial results for the second quarter of the fiscal year ending March 31, 2027 are scheduled to be announced on November 10,2026.
We deeply apologize to our shareholders, investors, and all other stakeholders for the significant inconvenience and concern caused by this matter.
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.
